Suppr超能文献

相似文献

2
Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance.
PLoS One. 2015 May 7;10(5):e0126350. doi: 10.1371/journal.pone.0126350. eCollection 2015.
3
ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
Antimicrob Agents Chemother. 2008 Nov;52(11):3851-62. doi: 10.1128/AAC.00463-08. Epub 2008 Aug 18.
5
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Antimicrob Agents Chemother. 2015 Oct 19;60(1):229-38. doi: 10.1128/AAC.02157-15. Print 2016 Jan.
7
Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
Antimicrob Agents Chemother. 2004 Apr;48(4):1256-71. doi: 10.1128/AAC.48.4.1256-1271.2004.
9
Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01231-16. Print 2017 Jan.
10
Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.02114-18. Print 2019 Jan.

引用本文的文献

1
The pre-mRNA splicing modulator pladienolide B inhibits germination and growth.
mSphere. 2025 Jun 23:e0024825. doi: 10.1128/msphere.00248-25.
2
mutation in decreases manogepix susceptibility owing to increased expression.
Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0150824. doi: 10.1128/aac.01508-24. Epub 2024 Dec 18.
3
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit .
J Fungi (Basel). 2024 Oct 7;10(10):698. doi: 10.3390/jof10100698.
4
Shining a light on the impact of antifungals on subcellular dynamics through fluorescence imaging.
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0080324. doi: 10.1128/aac.00803-24. Epub 2024 Oct 15.
5
Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals.
Mol Biotechnol. 2024 May;66(5):960-974. doi: 10.1007/s12033-023-01017-1. Epub 2024 Jan 11.
6
Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0113123. doi: 10.1128/aac.01131-23. Epub 2023 Nov 29.
7
Molecular Investigation of the Antitumor Effects of Monoamine Oxidase Inhibitors in Breast Cancer Cells.
Biomed Res Int. 2023 Oct 5;2023:2592691. doi: 10.1155/2023/2592691. eCollection 2023.
8
Azole potentiation in Candida species.
PLoS Pathog. 2023 Aug 31;19(8):e1011583. doi: 10.1371/journal.ppat.1011583. eCollection 2023 Aug.
9
Clorgyline Analogs Synergize with Azoles against Drug Efflux in .
J Fungi (Basel). 2023 Jun 13;9(6):663. doi: 10.3390/jof9060663.
10
The fungal expel of 5-fluorocytosine derived fluoropyrimidines mitigates its antifungal activity and generates a cytotoxic environment.
PLoS Pathog. 2022 Dec 27;18(12):e1011066. doi: 10.1371/journal.ppat.1011066. eCollection 2022 Dec.

本文引用的文献

2
Emerging opportunistic yeast infections.
Lancet Infect Dis. 2011 Feb;11(2):142-51. doi: 10.1016/S1473-3099(10)70218-8.
4
Targeting monoamine oxidase A in advanced prostate cancer.
J Cancer Res Clin Oncol. 2010 Nov;136(11):1761-71. doi: 10.1007/s00432-010-0835-6. Epub 2010 Mar 4.
5
Safety of triazole antifungal drugs in patients with cancer.
J Antimicrob Chemother. 2010 Mar;65(3):410-6. doi: 10.1093/jac/dkp464. Epub 2009 Dec 24.
9
Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
Yakugaku Zasshi. 2009 May;129(5):623-30. doi: 10.1248/yakushi.129.623.
10
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
FEMS Yeast Res. 2009 Jun;9(4):618-25. doi: 10.1111/j.1567-1364.2009.00504.x. Epub 2009 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验